These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 52768)

  • 1. Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses.
    Beare AS; Schild GC; Craig JW
    Lancet; 1975 Oct; 2(7938):729-32. PubMed ID: 52768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trials of live influenza A recombinants in man during natural antigenic change in 1971-1976.
    Beare AS; Kendal AP; Schild GC
    Med Microbiol Immunol; 1978 Nov; 166(1-4):91-8. PubMed ID: 723793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain.
    Medvedeva TE; Gordon MA; Ghendon YZ; Klimov AI; Alexandrova GI
    Acta Virol; 1983 Jul; 27(4):311-7. PubMed ID: 6195900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of influenza B virus recombinants and their testing in humans for attenuation and immunogenicity.
    Beare AS; Sherwood JE; Callow KA; Craig JW
    Infect Immun; 1977 Feb; 15(2):347-53. PubMed ID: 844900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAs of influenza virus recombinants derived from parents of known virulence for man.
    Florent G; Lobmann M; Beare AS; Zygraich N
    Arch Virol; 1977; 54(1-2):19-28. PubMed ID: 889441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiments in the preparation of live influenza B vaccines.
    Beare AS; Sherwood JE; Callow KA; Craig JW
    Dev Biol Stand; 1977 Jun 1-3; 39():85-9. PubMed ID: 604138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinants of influenza virus type B as potential live vaccine candidates: RNA characterization and evaluation in man.
    Lobmann M; Delem A; Jovanovic D; Peetermans J
    J Hyg (Lond); 1981 Aug; 87(1):43-52. PubMed ID: 7019320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza.
    Sabin AB
    Dev Biol Stand; 1976; 33():127-40. PubMed ID: 955265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man.
    Murphy BR; Chalhub EG; Nusinoff SR; Chanock RM
    J Infect Dis; 1972 Aug; 126(2):170-8. PubMed ID: 4626544
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of immunity to influenza: maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins.
    Jakeman KJ; Smith H; Sweet C
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1523-31. PubMed ID: 2732721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic techniques for the production of influenza vaccines (author's transl)].
    Teti G
    Ann Sclavo; 1980; 22(1):34-9. PubMed ID: 7018413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Live influenza vaccine strains.
    Lancet; 1975 Oct; 2(7938):755-7. PubMed ID: 52780
    [No Abstract]   [Full Text] [Related]  

  • 13. Laboratory and clinical evaluation of new live influenza virus vaccines. Need for minimum requirements.
    Huygelen C
    Dev Biol Stand; 1977 Jun 1-3; 39():155-60. PubMed ID: 342307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ciliary activity in organ cultures of ferret trachea in reference to genetic and biological characters in influenza virus strains.
    Diaz-Rodriguez P; Boudreault A
    Can J Microbiol; 1982 Jul; 28(7):809-14. PubMed ID: 6756625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-scale field trial with neuraminidase vaccine.
    Vonka V; Závadová H; Brůj J; Skocil V; Janout V; Uvizl M; Kotíková J
    Dev Biol Stand; 1977 Jun 1-3; 39():337-9. PubMed ID: 342313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of human influenza A viruses.
    Beare AS; Bynoe ML
    Br Med J; 1969 Oct; 4(5677):198-201. PubMed ID: 4900146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic variants of influenza A virus (PR8 strain). V. Virulence, antigenic potency, and cross-protection tests in mice of the original and second series.
    LOOSLI CG; HAMRE D; GERBER P
    J Exp Med; 1958 Jun; 107(6):857-68. PubMed ID: 13539310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United States.
    Rajão DS; Gauger PC; Anderson TK; Lewis NS; Abente EJ; Killian ML; Perez DR; Sutton TC; Zhang J; Vincent AL
    J Virol; 2015 Nov; 89(22):11213-22. PubMed ID: 26311895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of attenuated influenza viruses.
    Beare AS; Maassab HF; Tyrrell DA; Slepuskin AN; Hall TS
    Bull World Health Organ; 1971; 44(5):593-8. PubMed ID: 5316742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.